286 related articles for article (PubMed ID: 27483437)
1. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
3. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
[TBL] [Abstract][Full Text] [Related]
4. Frequent CD7 antigen loss in aggressive natural killer-cell leukemia: a useful diagnostic marker.
Yoo EH; Kim HJ; Lee ST; Kim WS; Kim SH
Korean J Lab Med; 2009 Dec; 29(6):491-6. PubMed ID: 20046078
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
6. Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia.
Li C; Tian Y; Wang J; Zhu L; Huang L; Wang N; Xu D; Cao Y; Li J; Zhou J
Transl Res; 2014 Jun; 163(6):565-77. PubMed ID: 24524877
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic features of aggressive natural killer cell leukemia].
Liu EB; Chen HS; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):810-4. PubMed ID: 22336205
[TBL] [Abstract][Full Text] [Related]
8. Aggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells.
Lima M; Spínola A; Fonseca S; Santos AH; Rodrigues J; Oliveira L; Queirós ML; Santos M; Gonçalves M; Lau C; Teixeira Mdos A; Gonçalves C; Marques C; Guerreiro M; Cunha M; Príncipe F; Coutinho J
Leuk Lymphoma; 2015 Jan; 56(1):103-12. PubMed ID: 24669939
[TBL] [Abstract][Full Text] [Related]
9. Extranodal NK/T cell lymphoma and aggressive NK cell leukaemia: evidence for their origin on CD56+bright CD16-/+dim NK cells.
Lima M
Pathology; 2015 Oct; 47(6):503-14. PubMed ID: 26166665
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
Kurt H; Jorgensen JL; Amin HM; Patel KP; Wang SA; Lin P; Kanagal-Shamanna R; Loghavi S; Thakral B; Khogeer HA; Jabbour EJ; Li S; Yin CC; Medeiros LJ; Khoury JD
Eur J Haematol; 2018 May; 100(5):444-454. PubMed ID: 29385279
[TBL] [Abstract][Full Text] [Related]
11. Mixed-phenotype large granular lymphocytic leukemia: a rare subtype in the large granular lymphocytic leukemia spectrum.
Neff JL; Rangan A; Jevremovic D; Nguyen PL; Chiu A; Go RS; Chen D; Morice WG; Shi M
Hum Pathol; 2018 Nov; 81():96-104. PubMed ID: 29949739
[TBL] [Abstract][Full Text] [Related]
12. Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia.
El Hussein S; Patel KP; Fang H; Thakral B; Loghavi S; Kanagal-Shamanna R; Konoplev S; Jabbour EJ; Medeiros LJ; Khoury JD
Am J Surg Pathol; 2020 Sep; 44(9):1235-1243. PubMed ID: 32590457
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Flow-Cytometry-Based Immunophenotyping Analysis for Accurate Diagnosis and Management of Extranodal NK/T Cell Lymphoma, Nasal Type.
Wang JC; Deng XQ; Liu WP; Gao LM; Zhang WY; Yan JQ; Ye YX; Liu F; Zhao S
Cytometry B Clin Cytom; 2020 Jan; 98(1):28-35. PubMed ID: 31313887
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue Sites.
Gao LM; Zhao S; Liu WP; Zhang WY; Li GD; Küçük C; Hu XZ; Chan WC; Tang Y; Ding WS; Yan JQ; Yao WQ; Wang JC
Am J Surg Pathol; 2016 Jun; 40(6):836-46. PubMed ID: 26975038
[TBL] [Abstract][Full Text] [Related]
15. Adult aggressive natural killer cell leukemia.
Zhang H; Meng Q; Yin W; Xu L; Lie L
Am J Med Sci; 2013 Jul; 346(1):56-63. PubMed ID: 23241562
[TBL] [Abstract][Full Text] [Related]
16. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
Nicolae A; Ganapathi KA; Pham TH; Xi L; Torres-Cabala CA; Nanaji NM; Zha HD; Fan Z; Irwin S; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2017 Jan; 41(1):67-74. PubMed ID: 27631517
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic Expression of CD3ε Heterodimers by Flow Cytometry Rapidly Distinguishes Between Mature T-Cell and Natural Killer-Cell Neoplasms.
Shi M; Nguyen P; Timm MM; Otteson GE; Horna P; Olteanu H; Jevremovic D
Am J Clin Pathol; 2020 Oct; 154(5):683-691. PubMed ID: 32589191
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias.
Oshimi K
Intern Med; 2017; 56(14):1759-1769. PubMed ID: 28717070
[TBL] [Abstract][Full Text] [Related]
19. [Aggressive NK-cell leukemia: report of nine cases and review of literature].
Sino-US Shanghai Leukemia Cooperative Group
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):116-9. PubMed ID: 16732967
[TBL] [Abstract][Full Text] [Related]
20. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.
Suzuki R; Suzumiya J; Nakamura S; Aoki S; Notoya A; Ozaki S; Gondo H; Hino N; Mori H; Sugimori H; Kawa K; Oshimi K;
Leukemia; 2004 Apr; 18(4):763-70. PubMed ID: 14961041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
